ATX West, MD&M West, Plastec West, West Pack, and Design & Manufacturing West is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Welcome to the Advanced Manufacturing West 2019 Presentation Store. Here you can view and download conference and/or show floor theater presentations before, during, and after the event. If you’re looking for a presentation from a specific session that you’re unable to find here, note that it’s likely because the presenter has not provided permission for external use or has not yet shared their presentation with us. Please check back after the event for a more complete catalogue of available presentations.

Leo PetrossianCo-Founder & CEO Neural Analytics

Leo is Co-Founder and CEO of Neural Analytics, Inc., and is an accomplished entrepreneur, engineer and nanotechnology expert with a passion for finding solutions to a shared problem using innovative technology. He has raised over $42M in venture financing, and led the evelopment of 2 medical devices in five years, both of which have obtained CE mark and FDA clearance. He is a nanotechnology expert with a passion for solving shared problems through innovative technology.

As the first engineer at Nabsys, a DNA sequencing start-up, Leo served as the Director of Nanofabrication for four years where he oversaw device design, fabrication, testing and outsourcing. His experience and interest in nanotechnology startups led him to co-found Nanotech Consulting, a firm dedicated to helping nanotechnology startups overcome their unique prototyping challenges during the early stages of venture initiation. He served as the Chief Technology Officer.

Following a cross-campus collaboration at UCLA, where he was pursuing an MBA, Leo co- founded Neural Analytics Inc., a medical robotics company developing and commercializing technologies to measure and track brain health. In just five years as CEO, he led development of the Lucid Robotic System (Lucid™ M1 Transcranial Doppler Ultrasound System® and NeuralBot™ System), a robotic assisted ultrasound platform that was recently FDA cleared. This technology integrates ultrasound, robotics and machine learning to assist clinicians to non- invasively monitor a patient's brain blood flow characteristics and provide actionable information to diagnose a variety of neurological disorders.

Presenting: